4//SEC Filing
BECK DOUGLAS 4
Accession 0001493152-18-015265
CIK 0001641631other
Filed
Nov 5, 7:00 PM ET
Accepted
Nov 6, 4:50 PM ET
Size
5.4 KB
Accession
0001493152-18-015265
Insider Transaction Report
Form 4
BECK DOUGLAS
Chief Financial Officer
Transactions
- Award
Stock Option (right to buy)
2018-11-02+85,000→ 85,000 totalExercise: $4.25Exp: 2022-11-01→ Common stock (85,000 underlying)
Footnotes (1)
- [F1]The options will vest as to 25% of the shares after 12 months of continuous service, and the balance will vest in equal monthly installments over the next 36 months of continuous service.
Documents
Issuer
AIT Therapeutics, Inc.
CIK 0001641631
Entity typeother
Related Parties
1- filerCIK 0001267110
Filing Metadata
- Form type
- 4
- Filed
- Nov 5, 7:00 PM ET
- Accepted
- Nov 6, 4:50 PM ET
- Size
- 5.4 KB